Atomo Diagnostics has secured an additional $1.08 million from New York-based Global Health Investment Fund, property developer Lang Walker and Grand Challenges Canada, among other investors. The Australian company is looking to enter into licensing and partnership agreements with consumer and professional diagnostic firms to advance marketing efforts for its single-use, rapid in-vitro diagnostic blood test.
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.